{"protocolSection":{"identificationModule":{"nctId":"NCT03196310","orgStudyIdInfo":{"id":"17-008"},"briefTitle":"Single Blinded First CMC Osteoarthritis Treatment","officialTitle":"Randomized Single Blinded First CMC Osteoarthritis Treatment: Therapy and Bracing Alone vs. Intra-Articular Corticosteroid Injection vs Intra-Articular Leukocyte Depleted Platelet Rich Plasma"},"descriptionModule":{"briefSummary":"Single blinded PRP vs. Corticosteroid vs. Placebo (normal saline) intra-articular injection for basal joint arthritis."},"conditionsModule":{"conditions":["Osteoarthritis Thumb"]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Stage 1-3 osteoarthritis of the basal joint\n\nExclusion Criteria:\n\n* Patients with Stage 4 1st carpometacarpal joint arthritis as described by Eaton\n* Patients who have received a corticosteroid injection in the last year to the 1st CMC joint on the proposed study side\n* Patients who have scaphotriquetral, radioscaphoid, or scaphotrapezial osteoarthritis\n* Patients who have concurrent DeQuervain's tenosynovitis or intersection syndrome or have been treated for either of these in the last 3 months\n* Patients undergoing evaluation of cervical radiculopathy\n* Patients with fibromyalgia or inflammatory rheumatic disease\n* Patients with Pressier disease, Kienbock's, or avascular necrosis of the scaphoid\n* Patients with any history of primary or secondary bone tumor\n* Patients that are pregnant or terminally ill","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]}}}